138 related articles for article (PubMed ID: 32713149)
1. Effective treatment with mepolizumab in a patient with refractory Wells syndrome.
Terhorst-Molawi D; Altrichter S; Röwert J; Magerl M; Zuberbier T; Maurer M; Bergmann KC; Metz M
J Dtsch Dermatol Ges; 2020 Jul; 18(7):737-739. PubMed ID: 32713149
[No Abstract] [Full Text] [Related]
2. Treatment of hypereosinophilic syndrome and eosinophilic dermatitis with reslizumab.
Kuruvilla M
Ann Allergy Asthma Immunol; 2018 Jun; 120(6):670-671. PubMed ID: 29496465
[No Abstract] [Full Text] [Related]
3. Treatment of recalcitrant eosinophilic cellulitis with adalimumab.
Sarin KY; Fiorentino D
Arch Dermatol; 2012 Sep; 148(9):990-2. PubMed ID: 22986848
[No Abstract] [Full Text] [Related]
4. Mepolizumab use: Post-approval academic practice experience.
Benjamin MR; Bochner BS; Peters AT
Ann Allergy Asthma Immunol; 2018 Jul; 121(1):126-128. PubMed ID: 29653234
[No Abstract] [Full Text] [Related]
5. [Eosinophilic cellulitis (Wells syndrome)].
de Winter S; Bergman W
Ned Tijdschr Geneeskd; 2001 Aug; 145(31):1521-2. PubMed ID: 11569459
[No Abstract] [Full Text] [Related]
6. Churg-Strauss syndrome and Wells syndrome: coincidence or pathogenetic association? A new case report.
Govoni M; Colina M; Cavazzini L; Trotta F
Clin Exp Rheumatol; 2007; 25(1 Suppl 44):S41. PubMed ID: 17428365
[No Abstract] [Full Text] [Related]
7. Recurrent, pruritic dermal plaques and bullae. Diagnosis: eosinophilic cellulitis (Wells syndrome).
Green WH; Yosipovitch G; Pichardo RO
Arch Dermatol; 2007 Jun; 143(6):791-6. PubMed ID: 17576951
[No Abstract] [Full Text] [Related]
8. Eosinophilic cellulitis of papulonodular presentation (Wells' syndrome).
Ghislain PD; Van Eeckhout P
J Eur Acad Dermatol Venereol; 2005 Mar; 19(2):226-7. PubMed ID: 15752298
[TBL] [Abstract][Full Text] [Related]
9. The role of interleukin 5 in asthma.
Varricchi G; Canonica GW
Expert Rev Clin Immunol; 2016 Sep; 12(9):903-5. PubMed ID: 27450970
[No Abstract] [Full Text] [Related]
10. Wells' syndrome associated with Churg-Strauss syndrome: correlation with mast cell distribution.
Huang CF; Chen YF; Wang WM; Chiang CP
Int J Dermatol; 2013 Feb; 52(2):214-6. PubMed ID: 22998535
[No Abstract] [Full Text] [Related]
11. Evidence for the efficacy and safety of anti-interleukin-5 treatment in the management of refractory eosinophilic asthma.
Hilvering B; Xue L; Pavord ID
Ther Adv Respir Dis; 2015 Aug; 9(4):135-45. PubMed ID: 25900924
[TBL] [Abstract][Full Text] [Related]
12. Wells syndrome and its relationship to Churg-Strauss syndrome.
Ratzinger G; Zankl J; Zelger B
Int J Dermatol; 2013 Aug; 52(8):949-54. PubMed ID: 23786445
[TBL] [Abstract][Full Text] [Related]
13. Clinical Course of Eosinophilic Cellulitis.
Ozawa H; Kuwano K; Manabe S; Ishihara T; Komatsu M; Kobayashi T; Yanagi H; Oki M; Takagi A
Tokai J Exp Clin Med; 2017 Dec; 42(4):143-146. PubMed ID: 29228410
[TBL] [Abstract][Full Text] [Related]
14. Anti-interleukin-5 antibody treatment (mepolizumab) in active eosinophilic oesophagitis: a randomised, placebo-controlled, double-blind trial.
Straumann A; Conus S; Grzonka P; Kita H; Kephart G; Bussmann C; Beglinger C; Smith DA; Patel J; Byrne M; Simon HU
Gut; 2010 Jan; 59(1):21-30. PubMed ID: 19828470
[TBL] [Abstract][Full Text] [Related]
15. Eosinophilic Cellulitis Possibly Due to Mosquito Bite With High IL-5 Production.
Mashima E; Sawada Y; Yamaguchi T; Ohmori S; Haruyama S; Yoshioka M; Okada E; Nakamura M
J Investig Allergol Clin Immunol; 2017; 27(2):149-150. PubMed ID: 28398209
[No Abstract] [Full Text] [Related]
16. Clinical efficacy of anti-IL-5 monoclonal antibody mepolizumab in the treatment of eosinophilic otitis media.
Iino Y; Takahashi E; Ida S; Kikuchi S
Auris Nasus Larynx; 2019 Apr; 46(2):196-203. PubMed ID: 30122651
[TBL] [Abstract][Full Text] [Related]
17. Wells' syndrome: a pathogenic role for circulating CD4+CD7- T cells expressing interleukin-5 mRNA.
Yagi H; Tokura Y; Matsushita K; Hanaoka K; Furukawa F; Takigawa M
Br J Dermatol; 1997 Jun; 136(6):918-23. PubMed ID: 9217826
[TBL] [Abstract][Full Text] [Related]
18. Eosinophilic cellulitis presented with semicircular pattern.
Karabudak O; Dogan B; Taskapan O; Harmanyeri Y
J Dermatol; 2006 Nov; 33(11):798-801. PubMed ID: 17073997
[TBL] [Abstract][Full Text] [Related]
19. Current update on eosinophilic lung diseases and anti-IL-5 treatment.
Samitas K; Rådinger M; Bossios A
Recent Pat Antiinfect Drug Discov; 2011 Sep; 6(3):189-205. PubMed ID: 21824072
[TBL] [Abstract][Full Text] [Related]
20. [Eosinophilic cellulitis (Wells syndrome)].
Plötz SG; Abeck D; Behrendt H; Simon HU; Ring J
Hautarzt; 2000 Mar; 51(3):182-6. PubMed ID: 10789080
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
